KLDO (Kaleido Biosciences) Total Assets: $50.14 Mil (As of Dec. 2021)


What is Kaleido Biosciences Total Assets?

Kaleido Biosciences KLDO -99.00% Total Assets is $50.14 Mil as of Dec. 2021.

Kaleido Biosciences's Total Assets for the quarter that ended in Dec. 2021 was $50.14 Mil.

Total Assets is connected with ROA %. Kaleido Biosciences's annualized ROA % for the quarter that ended in Dec. 2021 was -137.51%. Total Assets is also linked to Revenue through Asset Turnover. Kaleido Biosciences's Asset Turnover for the quarter that ended in Dec. 2021 was 0.01.

Kaleido Biosciences  (OTCPK:KLDO) Total Assets Explanation

Total Assets is connected with ROA %.

Kaleido Biosciences's annualized ROA % for the quarter that ended in Dec. 2021 is

ROA %=Net Income (Q: Dec. 2021 )/( (Total Assets (Q: Sep. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=-81.088/( (67.804+50.137)/ 2 )
=-81.088/58.9705
=-137.51 %

Note: The Net Income data used here is four times the quarterly (Dec. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Kaleido Biosciences's Asset Turnover for the quarter that ended in Dec. 2021 is

Asset Turnover
=Revenue (Q: Dec. 2021 )/( (Total Assets (Q: Sep. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=0.492/( (67.804+50.137)/ 2 )
=0.492/58.9705
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Kaleido Biosciences Total Assets Related Terms

Kaleido Biosciences Total Assets Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Total Assets Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Assets
Get a 7-Day Free Trial 30.75 85.33 82.31 59.34 50.14

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.34 105.03 84.29 67.80 50.14

Kaleido Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Kaleido Biosciences's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (A: Dec. 2021 )+Total Liabilities (A: Dec. 2021 )
=10.607+39.53
=50.14

Kaleido Biosciences's Total Assets for the quarter that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (Q: Dec. 2021 )+Total Liabilities (Q: Dec. 2021 )
=10.607+39.53
=50.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $50.14 Mil mean?
Kaleido Biosciences (KLDO) has a Total Assets of $50.14 Mil as of Dec. 2021. The total amount of assets as recorded on a company's balance sheet. View historical data on Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Total Assets too high?
Kaleido Biosciences' current Total Assets is $50.14 Mil.
How does Kaleido Biosciences' Total Assets compare to NPTX and GSTC?
Kaleido Biosciences' Total Assets of $50.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Kaleido Biosciences and its competitors. Kaleido Biosciences's current Total Assets is $50.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Total Assets of $50.14 Mil. The current Total Assets is $50.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Total Assets is $50.14 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.